Dulaglutide
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
Company n/r · Phase 4 · Completed · Enrollment 104
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Semaglutide followed by dulaglutide | n/r | n/r | n/r | n/r |
| Dulaglutide followed by semaglutide | n/r | n/r | n/r | n/r |
Not shown
- Semaglutide followed by dulaglutide: endpoint not reported
- Dulaglutide followed by semaglutide: endpoint not reported